Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels

LP Morssink*, B SikkemaRaddatz, [No Value] Beekhuis, BTHM deWolf, A Mantingh

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    33 Citations (Scopus)

    Abstract

    In this patient-control study, we examined the impact of placental mosaicism on the concentrations of maternal serum human chorionic gonadotropin (MShCG) and maternal serum alpha-fetoprotein (MSAFP) in the second trimester of pregnancy. Patient and control groups were selected from 2347 women with a singleton pregnancy, who underwent chorionic villous sampling in the first trimester and from whom second-trimester serum samples had been collected. The concentrations of both serum markers, expressed in multiples of the median (MOM), in 35 women with confined placental mosaicism (CPM) were compared with those in 70 controls with uncomplicated pregnancies. Elevated MSAFP or MShCG was defined as a concentration of greater than or equal to 2 . 0 MOM. Of the 35 pregnancies with CPM, none had an elevated MSAFP level, as opposed to two out of the 70 women (2 . 9 per cent) in the control group (P=NS). Nine women in the placental mosaicism group (26 per cent) had an MShCG level of greater than or equal to 2 . 0 MOM, compared with five in the control group (7 . 1 per cent; P=0 . 0135). Nineteen women in the placental mosaicism group (54 per cent) were screen-positive for Down's syndrome (cut-off 1:250), compared with 17 women (24 per cent) in the control group (P=0 . 0042; relative risk=2 .). The three highest MShCG levels were found in pregnancies with CPM that involved trisomy 16; all these women delivered a small-for-gestational age (SGA) infant. CPM, especially with trisomy 16, is associated with elevated levels of MShCG, but not with elevated levels of MSAFP. It is an important cause of false-positive results in serum screening programmes for fetal Down's syndrome. It is possible that abnormal MShCG levels in pregnancies with CPM result from a dysfunctional placenta, caused by chromosomally abnormal areas. We therefore recommend increased surveillance of pregnancies with unexplained elevated MShCG levels.

    Original languageEnglish
    Pages (from-to)845-851
    Number of pages7
    JournalPrenatal Diagnosis
    Volume16
    Issue number9
    Publication statusPublished - Sept-1996

    Keywords

    • maternal serum human chorionic gonadotropin (MShCG)
    • maternal serum alpha-fetoprotein (MSAFP)
    • confined placental mosaicism (CPM)
    • INTRAUTERINE GROWTH-RETARDATION
    • HUMAN CHORIONIC-GONADOTROPIN
    • SERUM ALPHA-FETOPROTEIN
    • UNIPARENTAL DISOMY
    • FETAL DEVELOPMENT
    • CHROMOSOME-16
    • PREGNANCIES
    • 2ND-TRIMESTER
    • CONFIRMATION
    • DELIVERY

    Fingerprint

    Dive into the research topics of 'Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels'. Together they form a unique fingerprint.

    Cite this